FDA approves J&J's Cypher stent for use in smaller blood vesselsSeptember 21st, 2009 FDA approves smaller version of J&J stentBRIDGEWATER, N.J. — Medical product conglomerate Johnson & Johnson said Monday the Food and Drug Administration approved a smaller version of its drug-coated stent, Cypher.
Gov't says single swine flu shot enough to protect kids 10 and older, but younger may need twoSeptember 21st, 2009 Gov't: Single swine flu shot enough for older kidsWASHINGTON — Studies of the new swine flu vaccine show children 10 and older will need just one shot for protection against swine flu — but younger kids will need two. The National Institutes of Health says that protection kicks in for older children within eight to 10 days, just like it does for adults.
Govt says 1 swine flu shot enough to protect kids 10 and older, but younger may need 2September 21st, 2009 Govt: 1 swine flu shot enough for older kidsWASHINGTON — Studies of the new swine flu vaccine show children 10 and older will need just one shot for protection — but younger kids almost certainly will need two. Protection kicks in for older children within eight to 10 days of the shot, just like it does for adults, the National Institutes of Health announced Monday.
People over 55 'less aware on cancer' than younger adultsSeptember 21st, 2009 LONDON - People who are above 55 years of age are less aware of how to reduce their risk of cancer than younger adults, revealed a survey in UK. The YouGov survey of almost 2,000 people, commissioned by The World Cancer Research Fund (WCRF), found that people in that age group were less likely to know that poor diet, being overweight and drinking alcohol all increase cancer risk.
Obama: First family wants to get swine flu vaccine, will 'stand in line like everybody else'September 20th, 2009 Obama: First family to follow rules on flu vaccineWASHINGTON — President Barack Obama says the first family will follow the rules like every one else on the swine flu vaccine. Obama says he's probably "fairly far down" the pecking order for being vaccinated.
Initial trickle of swine flu vaccine may be 3.4 million doses of nasal spray, CDC saysSeptember 18th, 2009 CDC: First swine flu vaccines may be nasal sprayATLANTA — The first doses of swine flu vaccine may all be the nasal spray version, government health officials said Friday. The government has said a trickle of vaccine will be available in early October, but on Friday they defined the size of that trickle — an estimated 3.4 million doses.
Persistent pain in younger people ages them by 20 yearsSeptember 17th, 2009 WASHINGTON - Persistent pain in younger people ages them by 20 to 30 years in terms of physical abilities, a new study suggests. The study established that people with pain develop functional limitations associated with aging at much earlier ages.
An oddity for illness, but welcome news for seniors: Swine flu largely targets youngSeptember 17th, 2009 Seniors largely spared of swine fluMIAMI — Seniors who for years have made flu shots a fall ritual are being sent to the end of the line for the swine flu vaccine. And the reason — their age group seems to have a bit of immunity — appears to have warded off most potential grumbling.
Weight gain in adulthood linked to prostate cancer riskSeptember 12th, 2009 WASHINGTON - Body size and weight gain in younger and older adulthood may help weigh a man's proneness to prostate cancer, according to a study by researchers at the University of Hawaii at Manoa's Cancer Research Center of Hawaii. Led by Dr. Brenda Hernandez, the researchers said that the risk varies among different ethnic groups
For the study, the researchers studied the relationship in a multiethnic population consisting of blacks, Japanese, Hispanics, Native Hawaiians and whites, and compared differences among age groups using the Multiethnic Cohort, a longitudinal study of men 45-75 years of age established in Hawaii and California from 1993-1996.
Who needs which flu vaccineSeptember 10th, 2009 Who needs which flu vaccine?Who needs vaccine against regular winter flu, and who should be first in line for the swine flu shot? There's lots of overlap. Regular flu vaccine is available now, and people who need it most include:
—Adults 50 and older.
Brain's face processing ability does reduce with ageSeptember 9th, 2009 WASHINGTON - A British study suggests that the ability to identify a face, when it is shown for only a fraction of a second, reduces as people age. Lead researcher Guillaume Rousselet, from the University of Glasgow, came to this conclusion after analysing electric activity from the brains of young and old people as they watched pictures of faces with cloud-like noise.
Here's what ups amyloid beta production in Alzheimer's patients' brainsSeptember 4th, 2009 WASHINGTON - A new class of medicines to effectively treat Alzheimer's disease may soon be available, for an international research group has shed light on how a fragment of a protein increases the production of the amyloid beta protein in the brain. The researchers say that knowing that the N60 fragment of the RanBP9 protein increases the production of the amyloid beta protein, which is present in excessive amounts in the brains of people with Alzheimer's disease, gives scientists a more specific focus for developing new drugs.
Cities, human brains evolved in similar waysSeptember 4th, 2009 WASHINGTON - Cities and human brains have evolved in strikingly similar ways, says a new study. Just as advanced mammalian brains require a robust neural network to achieve richer and more complex thought, large cities require advanced highways and transportation systems to allow larger and more productive population.
Swine flu deaths more common in older children, says 1st CDC study of virus' pediatric tollSeptember 3rd, 2009 CDC study: Swine flu deaths higher in older kidsATLANTA — The first detailed study of U.S. children killed by swine flu found the outbreak differs from ordinary flu in at least one puzzling respect: It appears to be taking a higher toll on school-age youngsters than on babies and toddlers.
FDA panel says Genzyme did not conduct study necessary to prove benefit of leukemia drugSeptember 1st, 2009 FDA panel wants more data on Genzyme cancer drugWASHINGTON — A panel of cancer experts has issued a negative review of a leukemia drug from Genzyme, saying more data is needed to establish its safety and efficacy for older patients. The Food and Drug Administration's oncology panel voted 9-3 Tuesday that Cambridge, Mass.-based Genzyme should be required to conduct a larger, comparison study to prove its drug is safe and effective.
